학술논문
Overall survival and central nervous system activity of crizotinib in ROS1-rearranged lung cancer—final results of the EUCROSS trial
Document Type
Article
Author
Michels, S.; Massutí, B.; Vasyliv, I.; Stratmann, J.; Frank, J.; Adams, A.; Felip, E.; Grohé, C.; Rodriguez-Abreu, D.; Bischoff, H.; Carcereny i Costa, E.; Corral, J.; Pereira, E.; Fassunke, J.; Fischer, R.N.; Insa, A.; Koleczko, S.; Nogova, L.; Reck, M.; Reutter, T.; Riedel, R.; Schaufler, D.; Scheffler, M.; Weisthoff, M.; Provencio, M.; Merkelbach-Bruse, S.; Hellmich, M.; Sebastian, M.; Büttner, R.; Persigehl, T.; Rosell, R.; Wolf, J.
Source
In ESMO Open February 2024 9(2)
Subject
Language
ISSN
2059-7029